mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | ||||||
|---|---|---|---|---|---|---|
| evidence | position | mutation | freq | annotation | gene | description |
| RA | 9,710 | T→C | 5.2% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
| RA | 35,814 | Δ1 bp | 22.1% | intergenic (+45/+63) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,817 | A→T | 22.2% | intergenic (+48/+60) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,850 | C→T | 25.7% | intergenic (+81/+27) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,858 | T→A | 28.2% | intergenic (+89/+19) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,876 | C→T | 39.5% | intergenic (+107/+1) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,913 | C→G | 22.6% | S213S (TCG→TCC) | tpn ← | IS431mec transposase |
| RA | 35,940 | G→A | 27.5% | R204R (CGC→CGT) | tpn ← | IS431mec transposase |
| RA | 35,970 | T→C | 53.9% | E194E (GAA→GAG) | tpn ← | IS431mec transposase |
| RA | 35,997 | T→C | 31.0% | T185T (ACA→ACG) | tpn ← | IS431mec transposase |
| RA | 36,015 | C→T | 30.8% | R179R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,087 | A→G | 50.9% | C155C (TGT→TGC) | tpn ← | IS431mec transposase |
| RA | 36,119 | C→T | 28.9% | V145I (GTA→ATA) | tpn ← | IS431mec transposase |
| RA | 36,124 | G→A | 50.4% | A143V (GCT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,133 | A→G | 27.6% | V140A (GTA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,161 | T→C | 28.1% | I131V (ATT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,174 | T→C | 28.5% | K126K (AAA→AAG) | tpn ← | IS431mec transposase |
| RA | 36,269 | C→T | 55.6% | A95T (GCA→ACA) | tpn ← | IS431mec transposase |
| RA | 36,315 | G→A | 53.6% | Y79Y (TAC→TAT) | tpn ← | IS431mec transposase |
| RA | 36,378 | C→T | 78.6% | L58L (TTG→TTA) | tpn ← | IS431mec transposase |
| RA | 36,413 | C→T | 47.5% | V47I (GTC→ATC) | tpn ← | IS431mec transposase |
| RA | 36,444 | C→T | 39.5% | R36R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,471 | A→G | 14.1% | S27S (AGT→AGC) | tpn ← | IS431mec transposase |
| RA | 36,479 | T→C | 9.1% | T25A (ACA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,581 | C→T | 18.6% | intergenic (‑30/‑493) | tpn ← / → USA300HOU_0028 | IS431mec transposase/hypothetical protein |
| RA | 76,180 | C→T | 18.8% | intergenic (+238/‑896) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,185 | G→A | 9.0% | intergenic (+243/‑891) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,265 | C→T | 26.3% | intergenic (+323/‑811) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,295 | T→C | 56.9% | intergenic (+353/‑781) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,322 | G→A | 56.3% | intergenic (+380/‑754) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,353 | G→A | 52.8% | intergenic (+411/‑723) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 92,987 | A→G | 6.4% | intergenic (‑72/‑65) | yrkD ← / → yrkE | hypothetical protein/hypothetical protein |
| RA | 96,897 | A→G | 7.8% | intergenic (+1413/+66) | gloB → / ← USA300HOU_0095 | hypothetical protein/hypothetical protein |
| RA | 96,901:1 | +G | 8.0% | intergenic (+1417/+62) | gloB → / ← USA300HOU_0095 | hypothetical protein/hypothetical protein |
| RA | 96,908 | Δ1 bp | 6.5% | intergenic (+1424/+55) | gloB → / ← USA300HOU_0095 | hypothetical protein/hypothetical protein |
| RA | 96,912:1 | +A | 6.4% | intergenic (+1428/+51) | gloB → / ← USA300HOU_0095 | hypothetical protein/hypothetical protein |
| RA | 99,276 | G→C | 7.6% | intergenic (+70/+2) | tfoX → / ← USA300HOU_0099 | hypothetical protein/possible MFS family major facilitator transporter |
| RA | 110,651 | C→T | 14.5% | D170D (GAC→GAT) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 110,660 | T→A | 20.6% | I173I (ATT→ATA) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 111,512 | A→G | 36.5% | S194S (TCA→TCG) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,516 | C→A | 35.9% | Q196K (CAA→AAA) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,560 | T→C | 15.2% | R210R (CGT→CGC) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,572 | C→T | 8.1% | D214D (GAC→GAT) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 168,350 | A→T | 7.0% | intergenic (+317/‑1187) | USA300HOU_0157 → / → USA300HOU_0160 | nucleotidase/hypothetical protein |
| RA | 168,354 | C→G | 6.1% | intergenic (+321/‑1183) | USA300HOU_0157 → / → USA300HOU_0160 | nucleotidase/hypothetical protein |
| RA | 217,036 | T→A | 5.7% | intergenic (‑203/+23) | argD ← / ← brnQ | ornithine‑‑oxo‑acid transaminase/possible LIVCS family branched chain amino acid:cation symporter |
| RA | 372,106 | T→A | 5.0% | intergenic (‑166/‑204) | USA300HOU_0339 ← / → lip1 | hypothetical membrane protein/triacylglycerol lipase |
| RA | 372,114 | C→A | 6.0% | intergenic (‑174/‑196) | USA300HOU_0339 ← / → lip1 | hypothetical membrane protein/triacylglycerol lipase |
| RA | 512,004 | T→C | 8.0% | intergenic (+72/‑789) | recR → / → rrs1 | recombination protein RecR/16S ribosomal RNA |
| RA | 512,643 | A→G | 52.6% | intergenic (+711/‑150) | recR → / → rrs1 | recombination protein RecR/16S ribosomal RNA |
| RA | 576,915 | C→G | 6.2% | intergenic (+338/‑1) | gltX → / → cysE | glutamate‑‑tRNA ligase/serine O‑acetyltransferase |
| RA | 614,172 | T→C | 8.4% | S828S (AGT→AGC) | sdrC → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrC |
| RA | 618,351 | T→C | 5.3% | D1151D (GAT→GAC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
| RA | 618,558 | T→C | 6.5% | S1220S (AGT→AGC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
| RA | 618,567 | T→C | 8.7% | D1223D (GAT→GAC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
| RA | 622,533 | T→C | 11.0% | D1032D (GAT→GAC) | sdrE → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrE |
| RA | 659,376 | T→A | 5.7% | intergenic (+399/‑283) | USA300HOU_0598 → / → USA300HOU_0600 | hypothetical protein/hypothetical protein |
| RA | 707,909 | A→T | 6.3% | M1M (TTG→ATG) † | mntB ← | ABC superfamily ATP binding cassette transporter, ABC protein |
| RA | 740,322 | G→C | 5.7% | intergenic (+549/+39) | pitA → / ← sle1 | possible PiT family inorganic phosphate transporter/possible LysM domain protein |
| RA | 779,970 | G→A | 5.1% | intergenic (+26/+46) | csbB → / ← saeS | possible glycosyltransferase/sensor histidine kinase SaeS |
| RA | 803,528 | C→T | 6.5% | intergenic (+36/+42) | USA300HOU_0750 → / ← dtpT | hypothetical protein/POT family proton (H+)‑dependent oligopeptide transporter |
| RA | 803,539 | A→G | 8.6% | intergenic (+47/+31) | USA300HOU_0750 → / ← dtpT | hypothetical protein/POT family proton (H+)‑dependent oligopeptide transporter |
| RA | 821,052 | T→A | 5.4% | intergenic (+129/+60) | glxK → / ← pepT | glycerate kinase/M20 family peptidase T |
| RA | 942,207 | A→G | 6.4% | intergenic (‑178/+71) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,210 | C→G | 6.4% | intergenic (‑181/+68) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,216 | T→A | 7.9% | intergenic (‑187/+62) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,221 | T→A | 7.9% | intergenic (‑192/+57) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,227 | C→G | 7.1% | intergenic (‑198/+51) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,230 | C→T | 6.5% | intergenic (‑201/+48) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 1,042,789 | T→C | 6.1% | intergenic (+19/‑903) | USA300HOU_0984 → / → USA300HOU_0985 | glycosyltransferase/possible iron (Fe3+) ABC superfamily ATP binding cassette transporter, binding protein |
| RA | 1,333,796 | T→G | 10.4% | V66G (GTT→GGT) | hflX → | GTP‑binding protein |
| RA | 1,343,619 | A→C | 5.2% | intergenic (+32/‑98) | USA300HOU_1250 → / → USA300HOU_1251 | hypothetical protein/hypothetical protein |
| RA | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD ← | oligopeptide ABC superfamily ATP binding cassette transporter, ABC protein |
| RA | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_1379 → | hypothetical membrane protein |
| RA | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | pepP ← | M24B family Xaa‑Pro dipeptidase |
| RA | 1,781,054 | C→T | 5.1% | intergenic (‑3079/+170) | tig ← / ← lysP | peptidylprolyl isomerase/APC family amino acid‑polyamine‑organocation transporter |
| RA | 1,857,867 | C→T | 7.8% | L169L (TTG→TTA) | USA300HOU_1728 ← | hypothetical protein |
| RA | 1,929,796 | T→C | 20.1% | intergenic (‑879/‑289) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,797 | G→A | 19.6% | intergenic (‑880/‑288) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,799 | C→A | 19.5% | intergenic (‑882/‑286) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,804 | A→G | 20.9% | intergenic (‑887/‑281) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,812 | G→A | 29.9% | intergenic (‑895/‑273) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,843 | Δ1 bp | 42.2% | intergenic (‑926/‑242) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,848 | C→A | 40.7% | intergenic (‑931/‑237) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,861 | T→C | 41.1% | intergenic (‑944/‑224) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,862:1 | +T | 34.3% | intergenic (‑945/‑223) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,865 | A→C | 34.8% | intergenic (‑948/‑220) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,866 | G→T | 40.9% | intergenic (‑949/‑219) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,867 | G→T | 41.6% | intergenic (‑950/‑218) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,870 | A→C | 41.1% | intergenic (‑953/‑215) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,872 | G→A | 41.2% | intergenic (‑955/‑213) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,873 | C→A | 41.1% | intergenic (‑956/‑212) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,875 | T→C | 42.1% | intergenic (‑958/‑210) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,917 | C→T | 30.8% | intergenic (‑1000/‑168) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,918 | A→G | 30.8% | intergenic (‑1001/‑167) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,925 | T→A | 27.5% | intergenic (‑1008/‑160) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,928 | T→A | 27.5% | intergenic (‑1011/‑157) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,930 | T→A | 27.5% | intergenic (‑1013/‑155) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,941 | A→T | 22.9% | intergenic (‑1024/‑144) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,946 | G→A | 19.3% | intergenic (‑1029/‑139) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | ygaD ← | ABC superfamily ATP binding cassette transporter, membrane protein |
| RA | 2,072,011:1 | +A | 7.4% | intergenic (+506/+67) | ykgB → / ← USA300HOU_1927 | hypothetical protein/hypothetical protein |
| RA | 2,072,028 | Δ1 bp | 7.3% | intergenic (+523/+50) | ykgB → / ← USA300HOU_1927 | hypothetical protein/hypothetical protein |
| RA | 2,198,373 | T→C | 6.2% | H152H (CAT→CAC) | kdpD → | sensor histidine kinase KdpD |
| RA | 2,211,248 | A→T | 9.2% | S9R (AGT→AGA) | USA300HOU_2086 ← | hypothetical protein |
| RA | 2,211,658 | G→A | 5.6% | intergenic (‑384/+162) | USA300HOU_2086 ← / ← yidC | hypothetical protein/hypothetical membrane protein |
| RA | 2,211,664 | Δ1 bp | 5.5% | intergenic (‑390/+156) | USA300HOU_2086 ← / ← yidC | hypothetical protein/hypothetical membrane protein |
| RA | 2,211,670 | C→A | 6.6% | intergenic (‑396/+150) | USA300HOU_2086 ← / ← yidC | hypothetical protein/hypothetical membrane protein |
| RA | 2,211,673 | T→G | 6.2% | intergenic (‑399/+147) | USA300HOU_2086 ← / ← yidC | hypothetical protein/hypothetical membrane protein |
| RA | 2,211,678:1 | +G | 6.2% | intergenic (‑404/+142) | USA300HOU_2086 ← / ← yidC | hypothetical protein/hypothetical membrane protein |
| RA | 2,243,499 | T→A | 5.4% | intergenic (+77/+32) | USA300HOU_2114 → / ← pyrG | hypothetical protein/CTP synthase |
| RA | 2,279,705 | G→A | 100% | intergenic (+1373/+6659) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
| RA | 2,372,413 | C→G | 5.7% | intergenic (‑5530/+28) | rpmC ← / ← pbuG | ribosomal protein L29/NCS2 family nucleobase:cation symporter‑2 |
| RA | 2,372,419 | C→T | 5.8% | intergenic (‑5536/+22) | rpmC ← / ← pbuG | ribosomal protein L29/NCS2 family nucleobase:cation symporter‑2 |
| RA | 2,430,685 | Δ1 bp | 5.8% | intergenic (‑109/‑276) | suhB ← / → USA300HOU_2294 | inositol‑phosphate phosphatase/transcriptional regulator |
| RA | 2,448,484 | A→G | 6.2% | intergenic (‑243/+34) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,448,493 | C→T | 8.2% | intergenic (‑252/+25) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,448,498 | C→T | 7.5% | intergenic (‑257/+20) | hipO ← / ← hutI | M20D subfamily peptidase/imidazolonepropionase |
| RA | 2,504,989 | T→C | 7.7% | intergenic (+293/+111) | USA300HOU_2365 → / ← gltT | hypothetical protein/DAACS family dicarboxylate/amino acid:sodium (Na+) or proton (H+) symporter |
| RA | 2,513,975 | C→T | 5.2% | R54Q (CGA→CAA) | nreA ← | hypothetical protein |
| RA | 2,517,782 | T→A | 5.2% | L950L (CTA→CTT) | narG ← | nitrate reductase alpha subunit |
| RA | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | murN → | FemAB family peptidoglycan biosynthesis protein |
| RA | 2,586,327 | G→T | 5.5% | I133I (ATC→ATA) | pepA ← | M42 family glutamyl aminopeptidase |
| RA | 2,607,228 | G→A | 6.5% | intergenic (‑25/+226) | USA300HOU_2469 ← / ← USA300HOU_2470 | hypothetical protein/dehydrogenase |
| RA | 2,608,820 | A→T | 5.9% | intergenic (‑671/+159) | USA300HOU_2470 ← / ← USA300HOU_2471 | dehydrogenase/hypothetical protein |
| RA | 2,608,825 | A→T | 10.6% | intergenic (‑676/+154) | USA300HOU_2470 ← / ← USA300HOU_2471 | dehydrogenase/hypothetical protein |
| RA | 2,630,523 | Δ1 bp | 7.1% | coding (1687/2823 nt) | fnbB ← | fibronectin‑binding protein B |
| RA | 2,680,123 | A→T | 5.1% | intergenic (+175/+357) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,137 | T→C | 5.4% | intergenic (+189/+343) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,141 | T→C | 5.0% | intergenic (+193/+339) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,680,166 | T→C | 9.6% | intergenic (+218/+314) | cbpD → / ← USA300HOU_2537 | possible secretory antigen/hypothetical protein |
| RA | 2,744,205 | A→G | 5.7% | intergenic (+142/+51) | fdaB → / ← mqo2 | fructose‑bisphosphate aldolase/malate dehydrogenase (acceptor) |
| RA | 2,744,213 | T→A | 6.5% | intergenic (+150/+43) | fdaB → / ← mqo2 | fructose‑bisphosphate aldolase/malate dehydrogenase (acceptor) |
| RA | 2,774,846 | A→G | 6.2% | S780S (AGT→AGC) | clfB ← | clumping factor B |
| RA | 2,774,969 | A→G | 8.0% | D739D (GAT→GAC) | clfB ← | clumping factor B |
| RA | 2,774,975 | A→G | 6.3% | D737D (GAT→GAC) | clfB ← | clumping factor B |
| RA | 2,833,387 | G→C | 6.4% | L70V (CTA→GTA) | USA300HOU_2672 ← | hypothetical protein |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | CP000730 | 190627 = | 111 (0.860) | 6 (0.050) | 6/232 | NT | 5.8% | intergenic (+3/+62) | cap5P/isdG1 | capsular polysaccharide biosynthesis protein Cap5P/heme‑degrading enzyme IsdG |
| ? | CP000730 | 190682 = | 94 (0.800) | intergenic (+58/+7) | cap5P/isdG1 | capsular polysaccharide biosynthesis protein Cap5P/heme‑degrading enzyme IsdG | |||||
| * | ? | CP000730 | = 511972 | 106 (0.820) | 9 (0.070) | 6/248 | NT | 8.1% | intergenic (+40/‑821) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
| ? | CP000730 | = 512004 | 101 (0.800) | intergenic (+72/‑789) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA | |||||
| * | ? | CP000730 | 512620 = | 126 (0.980) | 104 (1.180) +40 bp |
70/174 | NT | 54.6% | intergenic (+688/‑173) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
| ? | CP000730 | 1998278 = | NA (NA) | intergenic (‑6/+5) | USA300HOU_t0050/rrf4 | tRNA‑Val/5S ribosomal RNA | |||||
| * | ? | CP000730 | = 514652 | NA (NA) | 4 (0.030) | 3/236 | NT | NA | intergenic (+320/‑54) | rrs1/rrl1 | 16S ribosomal RNA/23S ribosomal RNA |
| ? | CP000730 | = 514681 | NA (NA) | intergenic (+349/‑25) | rrs1/rrl1 | 16S ribosomal RNA/23S ribosomal RNA | |||||
| * | ? | CP000730 | = 515946 | NA (NA) | 4 (0.030) | 3/240 | NT | NA | noncoding (1241/2921 nt) | rrl1 | 23S ribosomal RNA |
| ? | CP000730 | = 515981 | NA (NA) | noncoding (1276/2921 nt) | rrl1 | 23S ribosomal RNA | |||||
| * | ? | CP000730 | = 557240 | NA (NA) | 5 (0.040) | 3/246 | NT | NA | noncoding (169/1540 nt) | rrs2 | 16S ribosomal RNA |
| ? | CP000730 | = 557277 | NA (NA) | noncoding (206/1540 nt) | rrs2 | 16S ribosomal RNA | |||||
| * | ? | CP000730 | 920377 = | 100 (0.770) | 4 (0.030) | 4/226 | NT | 5.0% | coding (52/135 nt) | USA300HOU_0880 | hypothetical protein |
| ? | CP000730 | 920443 = | 62 (0.540) | coding (6/99 nt) | USA300HOU_0881 | hypothetical protein | |||||
| * | ? | CP000730 | 955970 = | 129 (1.000) | 11 (0.090) | 8/230 | NT | 9.2% | intergenic (‑192/+50) | glpQ2/argH | glycerophosphodiester phosphodiesterase/argininosuccinate lyase |
| ? | CP000730 | 956005 = | 100 (0.850) | intergenic (‑227/+15) | glpQ2/argH | glycerophosphodiester phosphodiesterase/argininosuccinate lyase | |||||
| * | ? | CP000730 | = 1265511 | 84 (0.650) | 6 (0.050) | 6/224 | NT | 7.0% | intergenic (+19/‑154) | fmhC/dprA | FemAB family peptidoglycan biosynthesis protein/SMF family nucleotide‑binding protein |
| ? | CP000730 | = 1265527 | 86 (0.750) | intergenic (+35/‑138) | fmhC/dprA | FemAB family peptidoglycan biosynthesis protein/SMF family nucleotide‑binding protein | |||||
| * | ? | CP000730 | 1525192 = | 117 (0.910) | 6 (0.050) | 6/232 | NT | 5.6% | intergenic (‑265/+57) | asnS/dnaQ | asparagine‑‑tRNA ligase/DNA‑directed DNA polymerase III epsilon subunit |
| ? | CP000730 | 1525239 = | 95 (0.810) | intergenic (‑312/+10) | asnS/dnaQ | asparagine‑‑tRNA ligase/DNA‑directed DNA polymerase III epsilon subunit | |||||
| * | ? | CP000730 | 1533866 = | 136 (1.050) | 7 (0.060) | 7/232 | NT | 5.7% | coding (207/576 nt) | USA300HOU_1400 | hypothetical protein |
| ? | CP000730 | 1533900 = | 108 (0.920) | coding (173/576 nt) | USA300HOU_1400 | hypothetical protein | |||||
| * | ? | CP000730 | = 1555341 | 108 (0.840) | 6 (0.050) | 4/234 | NT | 5.2% | intergenic (+37/+69) | fer/ribU | ferredoxin/hypothetical membrane protein |
| ? | CP000730 | = 1555365 | 119 (1.000) | intergenic (+61/+45) | fer/ribU | ferredoxin/hypothetical membrane protein | |||||
| * | ? | CP000730 | 1732959 = | 119 (0.920) | 9 (0.080) | 6/230 | NT | 8.7% | intergenic (+145/+92) | yvbT/USA300HOU_1624 | dehydrogenase/hypothetical protein |
| ? | CP000730 | 1733016 = | 80 (0.680) | intergenic (+202/+35) | yvbT/USA300HOU_1624 | dehydrogenase/hypothetical protein | |||||
| * | ? | CP000730 | = 1853642 | 110 (0.850) | 6 (0.050) | 5/238 | NT | 5.5% | intergenic (+45/+53) | acuC/ccpA | acetoin utilization protein AcuC/catabolite control protein A |
| ? | CP000730 | = 1853674 | 105 (0.870) | intergenic (+77/+21) | acuC/ccpA | acetoin utilization protein AcuC/catabolite control protein A | |||||
| * | ? | CP000730 | 1870532 = | 146 (1.130) | 8 (0.070) | 6/238 | NT | 5.6% | intergenic (‑10/‑325) | ytmP/USA300HOU_1740 | possible kanamycin kinase/hypothetical protein |
| ? | CP000730 | 1870584 = | 135 (1.120) | intergenic (‑62/‑273) | ytmP/USA300HOU_1740 | possible kanamycin kinase/hypothetical protein | |||||
| * | ? | CP000730 | = 2062972 | 92 (0.710) | 12 (0.100) | 8/226 | NT | 13.1% | intergenic (+53/+137) | pheA/sdcS | prephenate dehydratase/DASS family divalent anion:sodium (Na+) symporter |
| ? | CP000730 | = 2062986 | 78 (0.680) | intergenic (+67/+123) | pheA/sdcS | prephenate dehydratase/DASS family divalent anion:sodium (Na+) symporter | |||||
| * | ? | CP000730 | 2082639 = | 114 (0.880) | 6 (0.050) | 6/242 | NT | 5.3% | intergenic (+280/+345) | USA300HOU_1940/mapW2 | aminotransferase/cell surface protein MapW2 |
| ? | CP000730 | 2082667 = | 105 (0.850) | intergenic (+308/+317) | USA300HOU_1940/mapW2 | aminotransferase/cell surface protein MapW2 | |||||
| * | ? | CP000730 | 2256396 = | 118 (0.910) | 9 (0.080) | 8/226 | NT | 8.6% | intergenic (+49/+72) | deoD2/dps | purine‑nucleoside phosphorylase/Dps family stress protein |
| ? | CP000730 | 2256443 = | 86 (0.750) | intergenic (+96/+25) | deoD2/dps | purine‑nucleoside phosphorylase/Dps family stress protein | |||||
| * | ? | CP000730 | 2508438 = | 157 (1.220) | 9 (0.080) | 7/232 | NT | 6.4% | intergenic (+670/+81) | sarZ/narK | transcriptional regulator/MFS family major facilitator transporter, nitrate:nitrite antiporter |
| ? | CP000730 | 2508486 = | 119 (1.010) | intergenic (+718/+33) | sarZ/narK | transcriptional regulator/MFS family major facilitator transporter, nitrate:nitrite antiporter | |||||
| * | ? | CP000730 | 2716742 = | 119 (0.920) | 10 (0.080) | 10/232 | NT | 7.9% | intergenic (+50/+100) | ynzC/USA300HOU_2569 | hypothetical protein/possible lactoylglutatione lyase |
| ? | CP000730 | 2716816 = | 123 (1.040) | intergenic (+124/+26) | ynzC/USA300HOU_2569 | hypothetical protein/possible lactoylglutatione lyase | |||||
| * | ? | CP000730 | = 2872577 | 136 (1.050) | 14 (0.120) | 11/232 | NT | 9.6% | intergenic (‑107/+14) | rnpA/rpmH | ribonuclease P/hypothetical protein |
| ? | CP000730 | = 2872581 | 139 (1.180) | intergenic (‑111/+10) | rnpA/rpmH | ribonuclease P/hypothetical protein | |||||